A potential antibody treatment for COVID-19 from Singapore's DSO National Laboratories might be just a few months away from human trials. The country's largest defence R&D organisation said it has discovered five antibodies that could potentially neutralise the virus that causes COVID-19. Harvested from recovered patients, the antibodies act by binding and covering the part of the virus that enables it to enter the cells. Subscribe to our channel here:
Subscribe to our news service on Telegram:
Follow us:
CNA:
CNA Lifestyle:
Facebook:
Instagram:
Twitter:
0 Comments